|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Educational/Counseling/Training, Screening, Treatment
|
|
|
|
Active
|
|
|
|
65 and over
|
|
|
|
Other
|
|
|
|
IRB00000063 NCT00379743
|
|
|
|
|
|
|
|
Last Modified: 5/29/2008  First Published: 3/6/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Educational/Counseling/Training, Screening
|
|
|
|
Active
|
|
|
|
35 to 64
|
|
|
|
NCI
|
|
|
|
TATA-1900215717A1 1900215717A1, NCT00632047
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Screening
|
|
|
|
Approved-not yet active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
PRD 0801 CUMC AAD1382, NCT00702208
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Biomarker/Laboratory analysis, Screening
|
|
|
|
Active
|
|
|
|
18 to 80
|
|
|
|
Other
|
|
|
|
9100208476 NCT00155792
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Educational/Counseling/Training, Health services research, Screening
|
|
|
|
Approved-not yet active
|
|
|
|
21 and over
|
|
|
|
Other
|
|
|
|
RA-2006-025 NCT00379782
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Diagnostic, Educational/Counseling/Training, Screening
|
|
|
|
Active
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
1A0CMS300067 NCT00380055
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Health services research, Screening
|
|
|
|
Active
|
|
|
|
25 to 69
|
|
|
|
Other
|
|
|
|
H06-04032 NCT00461760
|
|
|
|